Jazz Pins Sativex US Hopes On Two Advanced Studies After First MS Spasticity Trial Flunks

 
• By Ayisha Sharma

The Irish firm’s cannabis-derived nabiximols spray missed the primary endpoint in a late-stage multiple sclerosis spasticity trial, but it is unfazed as hopes remain for two ongoing spasticity studies.  

Sativex Contains Several Cannabis Derivatives Including THC And CBD • Source: Shutterstock

More from Clinical Trials

More from R&D